Hybrigenics has named Dr. Alain Munoz to its board as a non-executive independent director. Munoz replaces Dr. Bernhard Ehmer, president of ImClone Systems, and will chair the clinical advisory board.

Munoz, cardiologist and anesthesiologist by training, has over 20 years’ experience in the pharmaceutical industry at senior management level with the Sanofi Group as R&D vice president and the French pharmaceutical company Fournier as VP of R&D and business development.